β-hydroxybutyrate, Glucose Metabolism and Prediabetes
NCT03889210 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2019-11-06
Summary
The study aims to investigate changes in blood glucose metabolism after administration of a ketone ester drink.
Conditions
Interventions
- OTHER
-
HVMN Ketone
Water-based, flavoured sport beverage
- OTHER
-
Placebo
Water, stevia, malic acid, and thickening agent
Sponsors & Collaborators
-
University of Auckland, New Zealand
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-01
- Primary Completion
- 2019-08-16
- Completion
- 2019-08-30
Countries
- New Zealand
Study Locations
More Related Trials
-
NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes
NCT00013910 ·Status: COMPLETED ·Phase: PHASE1
-
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
NCT02611232 ·Status: UNKNOWN ·Phase: PHASE2
-
GLP-1/Basal Insulin Combination Therapy
NCT02895672 ·Status: COMPLETED
-
Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1
NCT03560323 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Experimental Hyperketonemia on Myocardial Metabolism
NCT02814474 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes
NCT01435980 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
NCT01508923 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Intermediate Care Clinics for Diabetes
NCT00945204 ·Status: COMPLETED ·Phase: NA
-
Facilitated Release of Endogenous Enterokines
NCT04215328 ·Status: COMPLETED ·Phase: NA
-
Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance
NCT00085982 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study That Will Evaluate Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects (MK-0000-159)(COMPLETED)
NCT01055340 ·Status: COMPLETED ·Phase: PHASE1
-
The Microvascular Function of GLP-1 and Its Analogues
NCT01677104 ·Status: COMPLETED ·Phase: NA
-
GLP-1 and Microvascular Function in Type 2 Diabetes
NCT01740921 ·Status: COMPLETED ·Phase: NA
-
To Determine Tolerability to Glucagon Infusion in Obese Subjects
NCT02817659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
In Vitro Fertilization Impact on Metabolic Parameters
NCT03426228 ·Status: COMPLETED
-
Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
NCT00896298 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Early Diabetes Intervention Program
NCT01470937 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
NCT00856609 ·Status: COMPLETED ·Phase: PHASE3
-
Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency
NCT05541484 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes
NCT02777073 ·Status: COMPLETED ·Phase: NA
-
Effects of Human Leptin Replacement
NCT00657605 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Metabolic Effects of Ghrelin
NCT00771940 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance
NCT04532801 ·Status: WITHDRAWN ·Phase: PHASE1
-
Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
NCT02408705 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects
NCT03991299 ·Status: TERMINATED ·Phase: PHASE1/PHASE2